HomeTagsAmgen cholesterol drug cuts risk of first cardiac event by 25%

Amgen cholesterol drug cuts risk of first cardiac event by 25%
A

Continue reading...

Amgen cholesterol drug cuts risk of first cardiac event by 25%

Amgen cholesterol drug cuts risk of first cardiac event by 25% Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25%...

Subscribe for Exclusive Access

All

Exclusive Content

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

October 25, 2024

All

Exclusive Content

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

October 25, 2024

The World of Health & Medicine News

Amgen cholesterol drug cuts risk of first cardiac event by 25%

What Happens to Your Blood Sugar When You Eat Carrots Regularly

CRISPR gene-editing works to reduce high cholesterol in a new study

US FDA to drop black box warnings from menopause hormone therapies

Novo Nordisk, Emcure to launch weight-loss drug under new brand in India

Targeted vitamin D3 supplementation cuts risk of second heart attack in half, study finds

Carnosic acid in rosemary, the key to healthy skin regeneration

New Drug Could “Un-Stiffen” Aging Hearts, Offering Hope for the Most Common Form of Heart Failure

Countries make progress on WHO Pandemic Agreement annex on pathogen access and benefit sharing system

Lilly Moves Obesity Drug to Late-Stage Trials After It Shows Promise

Or continue exploring...

Amgen cholesterol drug cuts risk of first cardiac event by 25%
A

Continue reading...

Amgen cholesterol drug cuts risk of first cardiac event by 25%

Subscribe for Exclusive Access

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

The World of Health & Medicine News

Or continue exploring...

Amgen cholesterol drug cuts risk of first cardiac event by 25%A

Continue reading...

Subscribe for Exclusive Access

.tdi_173{margin-bottom:40px!important} EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

.tdi_192{margin-bottom:40px!important} EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

.tdi_211{margin-bottom:40px!important} EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

Amgen cholesterol drug cuts risk of first cardiac event by 25%
A

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources